Li C - Search Results

1

A Reference-Scaled Average Bioequivalence Study of Azithromycin Tablets Manufactured in China and the United States: An Open-Label, Randomized, Single-Dose, 3-Way Crossover Study in Healthy Chinese Subjects Under Fasted and Fed Conditions.

Ge B, Li C, Wei H, Ding Y, Wu M, Liu Y, Zhang K, Peng A. Ge B, et al. Among authors: li c. Clin Pharmacol Drug Dev. 2022 Oct;11(10):1147-1156. doi: 10.1002/cpdd.1132. Epub 2022 Jun 21. Clin Pharmacol Drug Dev. 2022. PMID: 35728921 Clinical Trial.

2

Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection.

Ding Y, Lou J, Chen H, Li X, Wu M, Li C, Liu J, Liu C, Li Q, Zhang H, Niu J. Ding Y, et al. Among authors: li c, li x, li q. Br J Clin Pharmacol. 2017 May;83(5):1056-1071. doi: 10.1111/bcp.13184. Epub 2016 Dec 20. Br J Clin Pharmacol. 2017. PMID: 27862178 Free PMC article. Clinical Trial.

3

Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations.

Li C, Xu J, Zheng Y, Chen G, Wang J, Ma L, Qiao Y, Niu J, Wu M, Zhang H, Li X, Chen H, Zhu X, Liu C, Ding Y. Li C, et al. Among authors: li x. Chem Pharm Bull (Tokyo). 2017 Jun 1;65(6):524-529. doi: 10.1248/cpb.c16-00866. Epub 2017 Apr 8. Chem Pharm Bull (Tokyo). 2017. PMID: 28392509 Free article.

4

Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects.

Ding Y, Zhang H, Li X, Li C, Chen G, Chen H, Wu M, Niu J. Ding Y, et al. Among authors: li c, li x. Hepatol Int. 2017 Jul;11(4):390-400. doi: 10.1007/s12072-017-9797-y. Epub 2017 May 30. Hepatol Int. 2017. PMID: 28560658 Clinical Trial.

5

Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virus.

Zhang H, Zhu X, Li Q, Lou J, Sun J, Shen Z, Chen H, Li X, Wu M, Li C, Liu J, Liu C, Hu Y, Wang J, Chen G, Ding Y, Niu J. Zhang H, et al. Among authors: li c, li x, li q. J Pharm Pharmacol. 2018 Jul;70(7):855-864. doi: 10.1111/jphp.12916. Epub 2018 Apr 6. J Pharm Pharmacol. 2018. PMID: 29630721 Clinical Trial.

6

Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects.

Zhang H, Li Q, Zhu X, Li C, Li X, Liu C, Hu Y, Chen G, Wei H, Wang J, Shen Z, Ding Y. Zhang H, et al. Among authors: li c, li x, li q. Cancer Chemother Pharmacol. 2018 Oct;82(4):615-623. doi: 10.1007/s00280-018-3645-1. Epub 2018 Jul 24. Cancer Chemother Pharmacol. 2018. PMID: 30043208 Clinical Trial.

7

Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditions.

Li X, Zhang H, Zhu X, Li C, Chen H, Liu J, Chen G, Wu M, Liu C, Shen Z, Niu J, Liu B, Ding Y. Li X, et al. Among authors: li c. Int J Clin Pharmacol Ther. 2018 Sep;56(9):434-442. doi: 10.5414/CP203241. Int J Clin Pharmacol Ther. 2018. PMID: 30049304 Clinical Trial.

8

Association of Variability and Pharmacogenomics With Bioequivalence of Gefitinib in Healthy Male Subjects.

Zhang H, Li Q, Zhu X, Wu M, Li C, Li X, Liu C, Shen Z, Ding Y, Hua S. Zhang H, et al. Among authors: li c, li x, li q. Front Pharmacol. 2018 Aug 7;9:849. doi: 10.3389/fphar.2018.00849. eCollection 2018. Front Pharmacol. 2018. PMID: 30131694 Free PMC article.

9

Evaluation of reference-scaled average bioequivalence of two oral formulations of abiraterone acetate in healthy Chinese subjects .

Li C, Ding Y, Yang D, Wang M, Hu Y, Zhang H, Zhu X, Chen G, Li X, Wu M, Liu J, Chen H, Liu C, Shen Z, Liu B. Li C, et al. Among authors: li x. Int J Clin Pharmacol Ther. 2018 Nov;56(11):562-570. doi: 10.5414/CP203295. Int J Clin Pharmacol Ther. 2018. PMID: 30220293 Clinical Trial.

10

Bioequivalence of Sarpogrelate in Healthy Chinese Subjects Under Fasting and Fed Conditions: A 4-Way Replicate Crossover Investigation by a Reference-Scaled Average Bioequivalence Approach.

Ding YH, Liu B, Lou JF, Sun JX, Wu M, Zhu XX, Chen GL, Zhang H, Li XJ, Chen H, Liu CJ, Shen ZW, Li CY. Ding YH, et al. Among authors: li xj, li cy. Clin Pharmacol Drug Dev. 2019 Aug;8(6):713-720. doi: 10.1002/cpdd.624. Epub 2018 Oct 16. Clin Pharmacol Drug Dev. 2019. PMID: 30325583 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82,226 results

Search Page